Antisense & RNAi Therapeutics Market Size, COVID-19 Impact Analysis By Regional Outlook (Europe, North America, Asia Pacific, Middle East & Africa And South America), Growth Potential, Price Trends, Competitive Market Share & Forecast 2023 - 2028 (Updated Version Available)
Antisense & RNAi Therapeutics Market Size, COVID-19 Impact Analysis By Regional Outlook (Europe, North America, Asia Pacific, Middle East & Africa And South America), Growth Potential, Price Trends, Competitive Market Share & Forecast 2023 - 2028 (Updated Version Available)
ID : MRI16113 | Date : Feb, 2021 | Pages :
180 | Region : Global |
Publisher : RI
The Antisense & RNAi Therapeutics market report provides a detailed analysis of global market size, value chain optimization, segmentation market growth, market share, competitive Landscape, regional and country-level market size, sales analysis, impact of domestic and global market players, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The global Antisense & RNAi Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2028, with a CAGR of xx%% in the forecast period of 2020 to 2028 and will expected to reach USD xx million by 2028, from USD xx million in 2020.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
RNA interference
SiRNA
MiRNA
Antisense RNA
By Application
Oncology
Cardiovascular
Renal
Neurodegenerative
Respiratory
Genetic
Infectious Diseases
Competitive Landscape and Antisense & RNAi Therapeutics Market Share Analysis
Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.):
Glaxo Smith Kline
Sanofi Aventis / Genzyme
Isis Pharmaceuticals/ Ionis Pharmaceuticals
Arbutus Biopharma Ltd.
Silence Therapeutics
Bio-Path Holdings Inc.
Calando Pharmaceuticals
ICo Therapeutics
Quark Pharmaceuticals
Rexhan Pharmaceuticals
Biomarin/Prosensa
Regulus Therapeutics
Rxi Pharmaceuticals
Silenseed
Dicerna Pharmaceuticals
Sirnaomics Inc.
Antisense & RNAi Therapeutics competitive landscape provides details by vendors, including company overview, company total revenue (financial), market potential, global presence, Antisense & RNAi Therapeutics sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Antisense & RNAi Therapeutics sales, revenue and market share for each player covered in this report.
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Antisense & RNAi Therapeutics market presented in the report. This section sheds light on the sales growth of different regional and country-level Antisense & RNAi Therapeutics markets. For the historical and forecast period 2015 to 2028, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Antisense & RNAi Therapeutics market.
Region Coverage (Regional Production, Demand & Forecast by Countries etc.): North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)
The research provides answers to the following key questions:
• What is the estimated growth rate and market share and size of the Antisense & RNAi Therapeutics market for the forecast period 2020 - 2028?
• What are the driving forces in the Antisense & RNAi Therapeutics market for the forecast period 2020 - 2028?
• Who are the prominent market players and how have they gained a competitive edge over other competitors?
• What are the market trends influencing the progress of the Antisense & RNAi Therapeutics industry worldwide?
• What are the major challenges and threats restricting the progress of the industry?
• What opportunities does the market hold for the prominent market players?
Table of Contents
Antisense & RNAi Therapeutics Market Report by Company, Regions, Types and Applications, Global Status and Forecast to 2025
1 Industry Overview of Antisense & RNAi Therapeutics
1.1 Antisense & RNAi Therapeutics Market Overview
1.1.1 Antisense & RNAi Therapeutics Product Scope
1.1.2 Market Status and Outlook
1.2 Global Antisense & RNAi Therapeutics Market Size and Analysis by Regions
1.2.1 North America
1.2.2 Europe
1.2.3 China
1.2.4 Rest of Asia Pacific
1.2.5 Central & South America
1.2.6 Middle East & Africa
1.3 Antisense & RNAi Therapeutics Market by Type
1.3.1 RNA interference
1.3.2 SiRNA
1.3.3 MiRNA
1.3.4 Antisense RNA
1.4 Antisense & RNAi Therapeutics Market by End Users/Application
1.4.1 Oncology
1.4.2 Cardiovascular
1.4.3 Renal
1.4.4 Neurodegenerative
1.4.5 Respiratory
1.4.6 Genetic
1.4.7 Infectious Diseases
2 Global Antisense & RNAi Therapeutics Competition Analysis by Players
2.1 Antisense & RNAi Therapeutics Market Size (Value) by Players (2018 and 2019)
2.2 Competitive Status and Trend
2.2.1 Market Concentration Rate
2.2.2 Product/Service Differences
2.2.3 New Entrants
2.2.4 The Technology Trends in Future
3 Company (Top Players) Profiles
3.1 Glaxo Smith Kline
3.1.1 Company Profile
3.1.2 Main Business/Business Overview
3.1.3 Products, Services and Solutions
3.1.4 Antisense & RNAi Therapeutics Revenue (Value) (2015-2020)
3.1.5 Recent Developments
3.2 Sanofi Aventis / Genzyme
3.2.1 Company Profile
3.2.2 Main Business/Business Overview
3.2.3 Products, Services and Solutions
3.2.4 Antisense & RNAi Therapeutics Revenue (Value) (2015-2020)
3.2.5 Recent Developments
3.3 Isis Pharmaceuticals/ Ionis Pharmaceuticals
3.3.1 Company Profile
3.3.2 Main Business/Business Overview
3.3.3 Products, Services and Solutions
3.3.4 Antisense & RNAi Therapeutics Revenue (Value) (2015-2020)
3.3.5 Recent Developments
3.4 Arbutus Biopharma Ltd.
3.4.1 Company Profile
3.4.2 Main Business/Business Overview
3.4.3 Products, Services and Solutions
3.4.4 Antisense & RNAi Therapeutics Revenue (Value) (2015-2020)
3.4.5 Recent Developments
3.5 Silence Therapeutics
3.5.1 Company Profile
3.5.2 Main Business/Business Overview
3.5.3 Products, Services and Solutions
3.5.4 Antisense & RNAi Therapeutics Revenue (Value) (2015-2020)
3.5.5 Recent Developments
3.6 Bio-Path Holdings Inc.
3.6.1 Company Profile
3.6.2 Main Business/Business Overview
3.6.3 Products, Services and Solutions
3.6.4 Antisense & RNAi Therapeutics Revenue (Value) (2015-2020)
3.6.5 Recent Developments
3.7 Calando Pharmaceuticals
3.7.1 Company Profile
3.7.2 Main Business/Business Overview
3.7.3 Products, Services and Solutions
3.7.4 Antisense & RNAi Therapeutics Revenue (Value) (2015-2020)
3.7.5 Recent Developments
3.8 ICo Therapeutics
3.8.1 Company Profile
3.8.2 Main Business/Business Overview
3.8.3 Products, Services and Solutions
3.8.4 Antisense & RNAi Therapeutics Revenue (Value) (2015-2020)
3.8.5 Recent Developments
3.9 Quark Pharmaceuticals
3.9.1 Company Profile
3.9.2 Main Business/Business Overview
3.9.3 Products, Services and Solutions
3.9.4 Antisense & RNAi Therapeutics Revenue (Value) (2015-2020)
3.9.5 Recent Developments
3.10 Rexhan Pharmaceuticals
3.10.1 Company Profile
3.10.2 Main Business/Business Overview
3.10.3 Products, Services and Solutions
3.10.4 Antisense & RNAi Therapeutics Revenue (Value) (2015-2020)
3.10.5 Recent Developments
3.11 Biomarin/Prosensa
3.12 Regulus Therapeutics
3.13 Rxi Pharmaceuticals
3.14 Silenseed
3.15 Dicerna Pharmaceuticals
3.16 Sirnaomics Inc.
4 Global Antisense & RNAi Therapeutics Market Size by Type and Application (2015-2020)
4.1 Global Antisense & RNAi Therapeutics Market Size by Type (2015-2020)
4.2 Global Antisense & RNAi Therapeutics Market Size by Application (2015-2020)
4.3 Potential Application of Antisense & RNAi Therapeutics in Future
4.4 Top Consumer/End Users of Antisense & RNAi Therapeutics
5 North America Antisense & RNAi Therapeutics Development Status and Outlook
5.1 North America Antisense & RNAi Therapeutics Market Size (2015-2020)
5.2 North America Antisense & RNAi Therapeutics Market Size and Market Share by Players (2018 and 2019)
6 Europe Antisense & RNAi Therapeutics Development Status and Outlook
6.1 Europe Antisense & RNAi Therapeutics Market Size (2015-2020)
6.2 Europe Antisense & RNAi Therapeutics Market Size and Market Share by Players (2018 and 2019)
7 China Antisense & RNAi Therapeutics Development Status and Outlook
7.1 China Antisense & RNAi Therapeutics Market Size (2015-2020)
7.2 China Antisense & RNAi Therapeutics Market Size and Market Share by Players (2018 and 2019)
8 Rest of Asia Pacific Antisense & RNAi Therapeutics Development Status and Outlook
8.1 Rest of Asia Pacific Antisense & RNAi Therapeutics Market Size (2015-2020)
8.2 Rest of Asia Pacific Antisense & RNAi Therapeutics Market Size and Market Share by Players (2018 and 2019)
9 Central & South America Antisense & RNAi Therapeutics Development Status and Outlook
9.1 Central & South America Antisense & RNAi Therapeutics Market Size (2015-2020)
9.2 Central & South America Antisense & RNAi Therapeutics Market Size and Market Share by Players (2018 and 2019)
10 Middle East & Africa Antisense & RNAi Therapeutics Development Status and Outlook
10.1 Middle East & Africa Antisense & RNAi Therapeutics Market Size (2015-2020)
10.2 Middle East & Africa Antisense & RNAi Therapeutics Market Size and Market Share by Players (2018 and 2019)
11 Market Forecast by Regions, Type and Application (2021-2028)
11.1 Global Antisense & RNAi Therapeutics Market Size (Value) by Regions (2021-2028)
11.1.1 North America Antisense & RNAi Therapeutics Revenue and Growth Rate (2021-2028)
11.1.2 Europe Antisense & RNAi Therapeutics Revenue and Growth Rate (2021-2028)
11.1.3 China Antisense & RNAi Therapeutics Revenue and Growth Rate (2021-2028)
11.1.4 Rest of Asia Pacific Antisense & RNAi Therapeutics Revenue and Growth Rate (2021-2028)
11.1.5 Central & South America Antisense & RNAi Therapeutics Revenue and Growth Rate (2021-2028)
11.1.6 Middle East & Africa Antisense & RNAi Therapeutics Revenue and Growth Rate (2021-2028)
11.2 Global Antisense & RNAi Therapeutics Market Size (Value) by Type (2021-2028)
11.3 Global Antisense & RNAi Therapeutics Market Size by Application (2021-2028)
12 Antisense & RNAi Therapeutics Market Dynamics
12.1 Antisense & RNAi Therapeutics Market Opportunities
12.2 Antisense & RNAi Therapeutics Challenge and Risk
12.2.1 Competition from Opponents
12.2.2 Downside Risks of Economy
12.3 Antisense & RNAi Therapeutics Market Constraints and Threat
12.3.1 Threat from Substitute
12.3.2 Government Policy
12.3.3 Technology Risks
12.4 Antisense & RNAi Therapeutics Market Driving Force
12.4.1 Growing Demand from Emerging Markets
12.4.2 Potential Application
13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs Trend/Customer Preference
13.3 External Environmental Change
13.3.1 Economic Fluctuations
13.3.2 Other Risk Factors
14 Research Finding/Conclusion
15 Appendix
Methodology
Analyst Introduction
Data Source
Research Methodology
The Market Reports Insights offers numerous solutions and its full addition in the research methods to be skilled at each step. We use wide-ranging resources to produce the best outcome for our customers. The achievement of a research development is completely reliant on the research methods implemented by the company. We always faithful to our clients to find opportunities by examining the global market and offering economic insights.
Market Reports Insights are proud of our widespread coverage that encompasses the understanding of numerous major industry domains. Company offers consistency in our research report, we also offers on the part of the analysis of forecast across a range of coverage geographies and coverage. The research teams carry out primary and secondary research to carry out and design the data collection methods.
The Company's Research Process Has the Following Advantages:
Information Procurement
The step comprises the procurement of market-related information or data via different methodologies & sources.
Information Investigation
This step comprises the mapping and investigation of all the information procured from the earlier step. It also includes the analysis of data differences observed across numerous data sources.
Highly Authentic Source
We offer highly authentic information from numerous sources. To fulfills the client’s requirement.
Market Formulation
This step entails the placement of data points at suitable market spaces in an effort to assume possible conclusions. Analyst viewpoint and subject matter specialist based examining the form of market sizing also plays an essential role in this step.
Validation & Publishing of Information
Validation is a significant step in the procedure. Validation via an intricately designed procedure assists us to conclude data-points to be used for final calculations.
Well researched, expertise analysts, well organized, concrete and current topics delivered in time.
- President and CEO
Very helpful to understand overview of business status, by customers, categories, timeless, and regions. Able to build the future business strategy on the basis of research report. Validated and researched information of reports.
- Senior Manager, Product Development
We are very thankful to (company name) for detailed research report delivering in short period of time. Good market research Company really commendable.
- Senior Manager, Product Development
Excellent services, unique and very professional. The effort taken to make sure relevance to our requirements ensured the best possible outcome.
